Literature DB >> 12670737

Prolactin regulation of estrogen receptor expression.

Jonna Frasor1, Geula Gibori.   

Abstract

The ability of the rat corpus luteum to respond to estrogen requires prolactin (PRL), which can stimulate the expression of the estrogen receptor (ER). This review will focus on the signaling mechanisms by which this occurs. Transcription of the genes encoding both ERalpha (Esr1) and ERbeta (Esr2) is stimulated by PRL through the Jak2-Stat5 pathway and Stat5-response elements that are located in each of the Esr promoters. A single nucleotide difference between these two response elements is responsible for the observation that either Stat5a or Stat5b can stimulate Esr1 transcription, whereas only Stat5b can activate transcription of Esr2. The tyrosine kinase Jak2 is required for PRL activation of Esr1 promoter activity; however, additional pathways are involved in PRL-induced Stat5b phosphorylation, nuclear translocation and DNA binding. In addition to the corpus luteum, PRL-induced ER expression might provide a mechanism for fine-tuning the responsiveness of other target tissues, such as the decidua and mammary gland, to these two hormones.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670737     DOI: 10.1016/s1043-2760(03)00030-4

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  40 in total

Review 1.  Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function.

Authors:  Sandra Gass; Jessica Harris; Chris Ormandy; Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

2.  The long and short of the prolactin receptor: the corpus luteum needs them both!

Authors:  Carlos Stocco
Journal:  Biol Reprod       Date:  2012-03-22       Impact factor: 4.285

Review 3.  Hormone action in the mammary gland.

Authors:  Cathrin Brisken; Bert O'Malley
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-25       Impact factor: 10.005

Review 4.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

5.  Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.

Authors:  Y Sangeeta Devi; Aurora Shehu; Carlos Stocco; Julia Halperin; Jamie Le; Anita M Seibold; Michal Lahav; Nadine Binart; Geula Gibori
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

6.  Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro.

Authors:  Qi YE; Qiao-yan ZHANG; Cheng-jian ZHENG; Yang WANG; Lu-ping QIN
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

Review 7.  Epigenetic mechanisms and the transgenerational effects of maternal care.

Authors:  Frances A Champagne
Journal:  Front Neuroendocrinol       Date:  2008-03-28       Impact factor: 8.606

8.  Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.

Authors:  Lisa M Arendt; Tara L Grafwallner-Huseth; Linda A Schuler
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

9.  Changes in estrogen receptor-alpha variant (ER-alpha36) expression during mouse ovary development and oocyte meiotic maturation.

Authors:  Bao-Zeng Xu; Sheng-Li Lin; Mo Li; Jia-Qiao Zhu; Sen Li; Ying-Chun Ouyang; Da-Yuan Chen; Qing-Yuan Sun
Journal:  Histochem Cell Biol       Date:  2008-10-28       Impact factor: 4.304

10.  Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation.

Authors:  Ricardo C Moraes; Hong Chang; Nikesha Harrington; John D Landua; Jonathan T Prigge; Timothy F Lane; Brandon J Wainwright; Paul A Hamel; Michael T Lewis
Journal:  Development       Date:  2009-03-18       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.